PlainRecalls
FDA Drug Moderate Class II Terminated

Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare Cop/Novartis, Deerfield, IL 60015, Manufactured by:Alza Corporation, Vacaville, CA 95688 for Novartis Consumer Health Inc., Parsippany, NJ 07054

Reported: November 16, 2016 Initiated: August 24, 2016 #D-0133-2017

Product Description

Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare Cop/Novartis, Deerfield, IL 60015, Manufactured by:Alza Corporation, Vacaville, CA 95688 for Novartis Consumer Health Inc., Parsippany, NJ 07054

Reason for Recall

Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.

Details

Recalling Firm
Sandoz Inc
Units Affected
42,740 cartons (24 count carton from 7 total lots)
Distribution
TN
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare Cop/Novartis, Deerfield, IL 60015, Manufactured by:Alza Corporation, Vacaville, CA 95688 for Novartis Consumer Health Inc., Parsippany, NJ 07054. Recalled by Sandoz Inc. Units affected: 42,740 cartons (24 count carton from 7 total lots).
Why was this product recalled?
Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 16, 2016. Severity: Moderate. Recall number: D-0133-2017.